|1.||Squires, H: 1 article (12/2011)|
|2.||Michaels, J: 1 article (12/2011)|
|3.||Simpson, E: 1 article (12/2011)|
|4.||Wong, R: 1 article (12/2011)|
|5.||Harnan, S: 1 article (12/2011)|
|6.||Stevens, Jw: 1 article (12/2011)|
|7.||Stansby, G: 1 article (12/2011)|
|8.||Meng, Y: 1 article (12/2011)|
|9.||Thomas, S: 1 article (12/2011)|
|10.||Ko, Kam-Ming: 1 article (06/2006)|
01/01/1985 - "A double-blind placebo-controlled study of Hexopal in the treatment of intermittent claudication."
06/01/1986 - "Inositol nicotinate in intermittent claudication."
01/01/1986 - "Treatment of intermittent claudication with inositol nicotinate."
09/01/1988 - "The therapeutic efficacy of inositol nicotinate (Hexopal) in intermittent claudication: a controlled trial."
04/01/1988 - "Does inositol nicotinate (Hexopal) influence intermittent claudication? "
|2.||Raynaud Disease (Raynaud's Disease)
03/01/1988 - "Although the mechanism of action remains unclear Hexopal is safe and is effective in reducing the vasospasm of primary Raynaud's disease during the winter months."
03/01/1988 - "This study examines the effects of 4 g/day of Hexopal or placebo, during cold weather, in 23 patients with primary Raynaud's disease. "
03/01/1988 - "A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease."
01/01/1979 - "Hexopal in Raynaud's disease."
03/01/1988 - "Hexopal (Hexanicotinate inositol) has shown promise in uncontrolled studies and its use in patients with Raynaud's disease may reduce such vasospasm. "
02/01/1977 - "A double-blind multiclinic trial compared the efficacies of pyridinolcarbamate and inositol niacinate in the patients with the ischemic ulcer due to chronic arterial occlusion. "
02/01/1977 - "A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion."
02/01/1977 - "A thrice-daily dose of 1.5 g of pyridinolcarbamate or 1.2 g of inositol niacinate was given at random to the patients during cold seasons, and the effectiveness of treatment was assessed mainly on the basis of the clinical course of the ischemic ulcer and the rest pain. "
|4.||Peripheral Vascular Diseases (Peripheral Vascular Disease)
|5.||Peripheral Arterial Disease
|1.||Inositol Niacinate (inositol nicotinate)
|8.||Niacin (Nicotinic Acid)